Hospira Logo (Erythrocin 01)
Erythrocin Lactobionate
Product Images NDC 0409-6476
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Erythrocin Lactobionate (NDC 0409-6476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Erythrocin Lactobionate Structural Formula (Erythrocin 02)
Figure 1 (Erythrocin 03)
Figure 2 (Erythrocin 04)
Figure 3 (Erythrocin 05)
Figure 4 (Erythrocin 06)
Figure 5 (Erythrocin 07)
Figure 6 (Erythrocin 08)
Hospira Logo (Erythrocin 09)
Principal Display Panel (500 mg Vial Label)
This text appears to be a product description for Erythromycin Lactobionate for Injection, USP. The product is a sterile powder for injection used for IV purposes only. The product comes in a single-dose ADD-Vantage vial and should be administered within 2 hours when mixed with DSW or within 8 hours when mixed with 0.9% NaCl. The vial should only be used with the ADD-Vantage Flexible Diluent Container. When mixed with the diluent, each 100 mL contains erythromycin actoblonate equivalent to 500 mg erythromycin. The product is distributed by Hospira, Inc.*
Principal Display Panel (500 mg Vial Tray Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
